Cargando…
ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) are a unique class of biotherapeutics of inherent heterogeneity and correspondingly complex absorption, distribution, metabolism, and excretion (ADME) properties. Herein, we consider the contribution of various components of ADCs such as various classes of warheads, l...
Autores principales: | Mou, Si, Huang, Yue, Rosenbaum, Anton I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698957/ https://www.ncbi.nlm.nih.gov/pubmed/31544891 http://dx.doi.org/10.3390/antib7040041 |
Ejemplares similares
-
Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics
por: Mu, Ruipeng, et al.
Publicado: (2022) -
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014) -
Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics
por: Hays, Amanda, et al.
Publicado: (2022) -
Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate
por: Huang, Yue, et al.
Publicado: (2023) -
Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs
por: Colbert, Alex, et al.
Publicado: (2014)